药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levamisole
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Bepridil.
Levamisole
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Bepridil.
Levamisole
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Bepridil.
Levamisole
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Bepridil.
Levamisole
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Bepridil.
Levamisole
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Bepridil.
Levamisole
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bepridil.
Levamisole
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bepridil.
Levamisole
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Bepridil.
Levamisole
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Bepridil.
Levamisole
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Bepridil.
Levamisole
Dabrafenib
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Bepridil.
Levamisole
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Bepridil.
Levamisole
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Bepridil.
Levamisole
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Bepridil.
Levamisole
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Bepridil.
Levamisole
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Bepridil.
Levamisole
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Bepridil.
Levamisole
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Bepridil.
Levamisole
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Bepridil.